FindTrial
Sign In

An observational study of intestinal CRE screening in patients undergoing hematopoietic stem cell transplantation for treatment decisions

An observational study of intestinal CRE screening in patients undergoing hematopoietic stem cell transplantation for treatment decisions

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200061312
Enrollment
Unknown
Registered
2022-06-20
Start date
2021-05-01
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases of the Hematologic system

Interventions

No Group:No intervention

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients to undergo hematopoietic stem cell transplantation.

Exclusion criteria

Exclusion criteria: 1. Functional failure of various organs, such as liver failure, kidney failure, heart failure; 2. Poor compliance or inability to cooperate with treatment.

Design outcomes

Primary

MeasureTime frame
CRE screening results;—

Secondary

MeasureTime frame
white blood cell count(WBC);c-reactive protein(CRP);procalcitonin(PCT);—

Countries

China

Contacts

Public ContactCao Weijie
Caoweijie2003@126.com+86 15093360671

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026